Latest Breaking News On - Roche basel institute of technology - Page 1 : vimarsana.com

/PRNewswire/ Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (A.I.) and.

United statesMarial maccecchiniLesliew kreis jrGunter blobelSusumu tonegawaNicole leberAnnovis bioExchange commission onCompany managementUniversity of baselSymphony pharmaceuticals annovisRoche basel institute of technologyCalifornia institute of technologyPrincipal at steelhead capital managementPrnewswire lantern pharma incSecurities exchange